Innov Labs

The submission presents severe red flags and contradictions. While the description claims a sophisticated deep-tech AI/ML platform for life sciences and drug discovery, the provided metrics are nonsensical. The target audience is listed as 'everyone', the technology used is merely 'Internet', and the traction claim ('most people have used my product') is entirely implausible for a specialized 2024 B2B biotech product. Additionally, citing an 'all time marketcap' of 2.5M instead of standard SaaS revenue indicates this may be a low-effort crypto token project rather than a genuine software solution. A quality multiplier of 0.5 was applied universally due to vague, unsupported, and highly dubious claims.